Title: Are Long-Acting β-Agonists Safe as Add-On Therapy for Asthma Patients?
Abstract: Asthma guidelines recommend adding a long-acting β-agonist (LABA) when asthma is not controlled with low-dose inhaled corticosteroids (ICS).* However,
Publication Year: 2016
Publication Date: 2016-08-31
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot